GENE ONLINE|News &
Opinion
Blog

iPS Cell
BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka
2022-07-28
Evotec Leverages Sernova’s Cell Pouch to Develop Diabetes Stem Cell Treatment
2022-05-18
Bio Japan 2021 Highlights: The Commercialization of iPS Cells and the Key to Improving Clinical Trials
2022-02-14
As Regenerative Medicine Grows in Japan, Challenges Remain
2021-12-24
Japanese Biotech Raises $37 Million in Series C to Develop Stem Cell Therapy for Heart Failure
2021-06-13
Fujifilm Cellular Dynamics Strikes Deal to Develop Off-The-Shelf Cell Therapies for Ocular Diseases
2021-05-20
Researchers Test Gene Augmentation Therapy in Patient-Derived Retinal Organoids to Find Eye Disease Cure
2021-02-23
Newly Created Immune-Evading Human Islets Could Potentially Treat Diabetes
2020-08-24
Cystic Fibrosis: ZFN Mediated Gene Editing Results in Functional CFTR Correction
2020-05-13
Rebuilding the Heart Realm with Stem Cells: A Conversation with Dr. Jun K. Yamashita of CiRA on Regenerative Medicine for Heart Diseases.
2019-09-26
Philadelphia-based Stem cell startup secures US$250 million funding
2019-07-09
Highlights on BioJapan 2018 – Updates on the Development of Cell Therapy and the Regenerative Medicine Ecosystem in Japan
2018-10-22
December 20, 1958: American Developmental Biologist James Thomson was Born
2017-12-19
November 18, 2012: Skin Cells Reveal DNA’s Genetic Mosaic, Reported by Yale University
2017-11-18
LATEST
Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
2024-07-12
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
2024-07-12
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
2024-07-12
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
2024-07-12
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
2024-07-11
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
EVENT
Scroll to Top